Evaluating the performance of the Framingham risk equations in a population with diabetes.
about
A randomised controlled trial of the effects of a web-based PSA decision aid, Prosdex. Protocol.Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts ProjectComparison of four cardiovascular risk prediction functions among Chinese patients with diabetes mellitus in the primary care setting.Heart disease and rheumatoid arthritis: understanding the risks.Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes.Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy.Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review.Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study.Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population.Dynamic microsimulation models for health outcomes: a reviewPrognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with type 2 diabetes.Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population.Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk CohortCoronary artery disease risk assessment from unstructured electronic health records using text mining.Cardiovascular risk assessment scores for people with diabetes: a systematic reviewPrediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study.Subclinical cardiovascular disease assessment in persons with diabetes.Multi-parameter regression survival modeling: An alternative to proportional hazards.Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial.[Evaluation of cardiovascular risk according to Framingham criteria in patients with type 2 diabetes].Psoriasis and the Framingham risk score in a Danish hospital cohort.Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.Assessment of cardiovascular risk in adults with type 2 diabetes and metabolic syndrome: Framingham versus UKPDS equations.
P2860
Q33301596-6312E1F9-8478-4B68-8AC0-750285B4B299Q33307064-7FC948DB-35F0-4961-918F-753A173419DFQ34299683-5F14E8B5-EF5A-4523-830C-F321957C1E74Q35019085-B755701D-CC65-4737-8640-A83542F39256Q35620177-B6C6928B-B755-4E69-930D-70F5C1A4A436Q35686464-65BD50D1-9400-4F61-AC8F-8E6E240A4E50Q35772791-7CEB297A-E901-458A-97CD-9CFCF8A73C12Q35905575-924594AF-94B8-4292-8BB6-12D5EF43A583Q35976480-BFA30FD4-C0CA-4A40-B233-1BA3A04BE2ABQ36116257-62BAC204-7252-40DF-868F-EC13A81BE3E0Q36239901-183E87AA-EBF2-4EA8-9C39-28FCB3709231Q36766928-636E97DD-0261-466C-8692-3A0449009596Q37139421-B65354CF-A461-40AF-B4BB-7DCD7BC29FA7Q37175869-7F82A4DB-8D8B-46A6-940A-E95232EA62A4Q37348704-5DD6B598-26CA-48F3-A0FB-5A4696DB181DQ37400825-ED125ACD-F669-4275-887E-AA2994396F1DQ38093066-F349BA51-75B6-43EC-9093-9FFE295DE1E6Q39148278-1DB36668-2CD1-4D5D-AA74-67F859EE0CD2Q44566407-DF7B1D54-51B1-402B-B733-51945DFEC60CQ44675716-FB6D3D72-3728-49AE-BD32-0CFF0B5B416DQ45717444-84397095-8430-4156-8ED1-0C59814BDA78Q46669142-976775D7-725E-48B4-8F59-8DC8FB339854Q50451370-6C623120-8504-43A5-865B-63988ADE533D
P2860
Evaluating the performance of the Framingham risk equations in a population with diabetes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Evaluating the performance of ...... in a population with diabetes.
@en
Evaluating the performance of ...... in a population with diabetes.
@nl
type
label
Evaluating the performance of ...... in a population with diabetes.
@en
Evaluating the performance of ...... in a population with diabetes.
@nl
prefLabel
Evaluating the performance of ...... in a population with diabetes.
@en
Evaluating the performance of ...... in a population with diabetes.
@nl
P2093
P2860
P1433
P1476
Evaluating the performance of ...... in a population with diabetes.
@en
P2093
Griffiths JD
Hopkinson P
Williams JE
P2860
P304
P356
10.1111/J.1464-5491.2004.01139.X
P577
2004-04-01T00:00:00Z